The β-site amyloid precursor protein cleaving enzyme 1 (Bace1) has been associated with cognitive dysfunction, amyloid deposition and neuroinflammation and its levels in the cerebrospinal fluid of MS patients have been implicated in the severity of MS disease. The gene discussed is BACE1; the disease is myeloid sarcoma.